One recent example of a controversial DNA test in cats was the A31P and A74T variants in myosin-binding protein C3 (MYBPC3) for hypertrophic cardiomyopathy (HCM) [3]. This evidence concerns the gene MYBPC3 and hypertrophic cardiomyopathy.